IL197908A0 - Buprenorphine-containing non-pressurised spray composition for transmucosal administration - Google Patents

Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Info

Publication number
IL197908A0
IL197908A0 IL197908A IL19790809A IL197908A0 IL 197908 A0 IL197908 A0 IL 197908A0 IL 197908 A IL197908 A IL 197908A IL 19790809 A IL19790809 A IL 19790809A IL 197908 A0 IL197908 A0 IL 197908A0
Authority
IL
Israel
Prior art keywords
buprenorphine
containing non
transmucosal administration
spray composition
pressurised spray
Prior art date
Application number
IL197908A
Original Assignee
Pharmasol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasol Ltd filed Critical Pharmasol Ltd
Publication of IL197908A0 publication Critical patent/IL197908A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL197908A 2006-10-18 2009-04-05 Buprenorphine-containing non-pressurised spray composition for transmucosal administration IL197908A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0620661.9A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
PCT/GB2007/050639 WO2008047163A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Publications (1)

Publication Number Publication Date
IL197908A0 true IL197908A0 (en) 2009-12-24

Family

ID=37507923

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197908A IL197908A0 (en) 2006-10-18 2009-04-05 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Country Status (8)

Country Link
EP (1) EP2081574A1 (en)
CN (1) CN101573116A (en)
AU (1) AU2007311621A1 (en)
CA (1) CA2666581A1 (en)
GB (2) GB0620661D0 (en)
IL (1) IL197908A0 (en)
WO (1) WO2008047163A1 (en)
ZA (1) ZA200902123B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
NZ594545A (en) 2006-07-21 2012-12-21 Biodelivery Sciences Int Inc Transmucosal delivery devices with enhanced uptake containing fentanyl or buprenorphine
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
BRPI0811319A2 (en) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc FLUID COMPOSITION, METHOD FOR FORMATION OF A FLUID COMPOSITION, BIODEGRADABLE IMPLANT FORMED IN SITU, METHOD FOR FORMATION OF A BIODEGRADABLE IMPLANT, KIT, IMPLANT AND TREATMENT METHOD
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB2481619B (en) * 2010-06-30 2012-06-20 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
SG10202012743WA (en) * 2011-12-21 2021-01-28 Biodelivery Sciences Int Inc Transmucosal drug delivery devices for use in chronic pain relief
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CN108463214A (en) 2015-10-27 2018-08-28 因塞斯发展股份有限公司 liquid buprenorphine formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274307A1 (en) * 2000-06-22 2002-01-02 Pharmasol Ltd Pharmaceutical compositions
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
WO2004071491A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
AU2005238962B2 (en) * 2004-04-23 2011-05-26 Philip Morris Products S.A. Aerosol generators and methods for producing aerosols

Also Published As

Publication number Publication date
AU2007311621A1 (en) 2008-04-24
WO2008047163A1 (en) 2008-04-24
ZA200902123B (en) 2010-04-28
EP2081574A1 (en) 2009-07-29
GB2456434A (en) 2009-07-22
CA2666581A1 (en) 2008-04-24
CN101573116A (en) 2009-11-04
GB0905120D0 (en) 2009-05-06
GB0620661D0 (en) 2006-11-29

Similar Documents

Publication Publication Date Title
IL197908A0 (en) Buprenorphine-containing non-pressurised spray composition for transmucosal administration
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
SI2101740T1 (en) New non-abusable pharmaceutical composition comprising opioids
IL195248A0 (en) Atomiser
HK1138732A1 (en) Pharmaceutical compositions
ZA200710734B (en) Compositions for drug delivery
IL248492A0 (en) Pharmaceutical compositions for intraventricular delivery
GB0610322D0 (en) Novel pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
ZA200806929B (en) Nebulizer formulation
ZA201103347B (en) Pharmaceutical aerosol composition
GB0621494D0 (en) Betamethasone spray
EP2124959A4 (en) Pharmaceutical composition
EP2097074A4 (en) Topical pharmaceutical composition
EP2109454A4 (en) Glp-1 pharmaceutical compositions
GB2443161B (en) Clobetasol spray
GB0515212D0 (en) Compositions for intranasal administration
GB0600032D0 (en) Pharmaceutical composition
GB0617578D0 (en) Pharmaceutical composition
GB0612696D0 (en) Pharmaceutical composition
ZA200904725B (en) GLP-1 Pharmaceutical compositions
ZA200808030B (en) Pharmaceutical compositions
GB0611079D0 (en) Pharmaceutical compositions